We have defined the boundaries of the a sequence from human cytomegalovirus (CMV) strain Towne, characterized internal variability and determined the position of the cleavage site used to generate genomic termini. The cleavage site is positioned a fixed distance from two stretches of sequence homology that have been observed near the ends of many herpesvirus genomes. Unlike a comparable region in CMV (AD 169), the CMV (Towne) a sequence has a relatively low level of variability within the a sequence and its structure is stable through repeated virus passage.
junction could provide the cis signals necessary for packaging into HSV-1 capsids (Spaete & Mocarski, 1984 , establishing the functional homology of the CMV and HSV a sequences. Although we reported certain structural features which suggested that the region contained the a sequence, we did not find the characteristic direct repeats (DR1) that flank HSV a sequences and therefore we could not determine the structural boundaries of the CMV a sequence at that time. Our data (Spaete & Mocarski, 1985a) on the CMV (Towne) a sequence, differed in several important ways from those of Tamashiro et al. (1984) and Tamashiro & Spector (1986) , who studied this region of CMV (AD169): (i) the CMV (AD169) a sequence appeared to contain a DR1 ; (ii) the level of heterogeneity in this region of CMV (AD169) was more complex than the simple a sequence amplification observed in HSV-1 and CMV (Towne); (iii) unlike CMV (AD169), all genomic termini contained at least one a sequence in CMV (Towne); and (iv) unlike CMV (Towne) the L terminus of CMV (AD169) appeared to carry an amplified sequence (class III) not present at the S terminus. Extensive sequence homology does exist between the CMV (Towne) and CMV (AD169) a sequences ( Fig. 1) , including a short stretch of sequence homologous to the HSV-1 a sequence (Spaete & Mocarski, 1985a; Tamashiro et al., 1984) . We previously invoked this homology to explain our observation that this region could function as an HSV-1 cleavage/packaging signal. The short region of homology has been observed in a number of herpesviruses (Albrecht et al., 1985; Bankier et al., 1985; Davison, 1984; Davison & Wilkie, 1981; Matsuo et al., 1984; Mocarski & Roizman, 1981; and is always positioned near the cleavage site. Here we report the precise boundaries of the a sequence of CMV (Towne) and show that the previously observed homology is appropriately spaced from the cleavage site generating the CMV genomic termini. Although the CMV (Towne) a sequence is not as heterogeneous as that of CMV (AD169), we characterize a region of intra-a sequence variability and demonstrate its stability upon passage. The heterogeneity observed in CMV (AD169) is unstable on passage (Tamashiro & Spector, 1986) . Our observations show that the high degree of instability and heterogeneity observed in the CMV (AD 169) L-S junction is not characteristic of another CMV strain. The level of variability observed in the CMV (Towne) genome is similar to that observed in HSV-1 a sequences. In order to determine the structural domain of the CMV (Towne) a sequence, we used a rationale previously applied to HSV-1 (Mocarski & Roizman, 1981) . Plasmid-cloned fragments containing two a sequences were obtained for comparison to our previously reported L-S junction sequence, which our current analysis showed to have one a sequence. Furthermore, to determine the position of the cleavage site generating genomic termini, a cleavage which appears to occur in a region between two tandem a sequences in HSV-1 (Mocarski & Roizman, 1982) , the nucleotide sequence of an S terminal clone was determined. Besides establishing its boundaries, this analysis revealed the level of sequence variability found within the a sequence. Observations by Tamashiro et al. (1984) and Tamashiro & Spector (1986) on the CMV (AD169) L-S junction and termini had indicated a high degree of sequence variability within this region and it was therefore of particular interest to analyse the CMV (Towne) genome comparatively.
The plasmid clones containing fragments from the L-S junction and S terminus of the CMV (Towne) genome are depicted in Fig. 1 . We used pMT11, a low copy number pBR322-derived plasmid vector (Spaete & Mocarski, 1985b) and Escherichia coli strain HBIO1 as a host. All cloning techniques have been described in detail (Mocarski & Roizman, 1981; Spaete & Frenkel, 1982; Spaete & Mocarski, 1985a, b) . L-S junction fragments bearing one and two a sequences were cloned and compared by restriction mapping ( Fig. 1 ) and nucleotide sequence determination (see below). Plasmid clones pON231 and pON230 were examples of BamHI ZEcoRI M junction-spanning fragments with one and two a sequences, respectively, and pON232 carried the BamHI Z-EcoRI Z junction fragment with two a sequences. The plasmid clone pON229 represents an S-terminal clone of the EcoRI M fragment with a single a sequence which has been cloned with the aid ofa BamHI linker added to the CMV genomic termini as previously described for HSV-1 (Mocarski & Roizman, 1982 ), pON208 has been described and sequenced (Spaete & Mocarski, 1985a) .
Determining the nucleotide sequence across the a to a boundary of clones pON230 and pON232, shown in the lower part of Fig. 2 , allowed us to position the boundaries of the a sequence precisely and unambiguously because both clones were identical in this region. We compared the sequence of these clones with our previously reported sequence of the CMV (Towne) L-S junction region (Spaete & Mocarski, 1985 a) . The domain of the CMV a sequence is indicated in Fig. 2 by the transition from b sequence to a sequence at nucleotides 171 to 172 and from a sequence to c sequence at nucleotides 933 to 934 on the CMV (Towne) L-S junction sequence. The 762 bp CMV (Towne) a sequence is larger than any HSV counterpart studied to date and is also larger than the CMV (AD169) a sequence (Tamashiro et al., 1984; Tamashiro & Spector, 1986) . As mentioned previously (Spaete & Mocarski, 1985 a) , the L-S junction of CMV (Towne) differs from that of CMV (AD169) by not having a direct repeat (called 'DRI' by Tamashiro et al., 1984) flanking the region as shown comparatively in Fig. 2 . We used the boundaries of the CMV (Towne) a sequence to compare the L-S junction sequence from both strains. It would appear that the 'rightward DRI' of CMV (AD169), for which there is a homologous region in CMV (Towne), lies entirely within the a sequence, 8 bp from the a to a or a to c boundary. Most of the 'leftward DRI', which is absent in CMV (Towne~, appears to fall outside the CMV (Towne) a sequence region (i.e. in the b sequence, although it overlaps 4 bp with the b to a boundary). It should be noted that, although the HSV-1 a sequence is naturally flanked by direct repeats, called DR1 (Mocarski & Roizman, 1981 , which have no sequence homology to any region of the CMV a sequence, we (Mocarski & Roizman, 1982; Mocarski et al., 1985a; Spaete & Mocarski, 1985a ) and others Varmuza & Smiley, 1985) have demonstrated that two copies of DR 1 are not necessary for a sequence function.
The nucleotide sequence of the S-terminal clone, pON229, confirmed the assignment of the a sequence domain described above, and established that the likely cleavage site used to generate genomic ends was positioned appropriately from the 'herpes pac homology' as has been shown , 1984) . The transition from b sequence to a sequence and from a sequence to c sequence determined on CMV (Towne) in the present work is indicated by arrowheads between nucleotides 171 and 172 and 933 and 934, respectively, above the CMV (Towne) sequence. The regions of degenerate tandem repeats and herpes pac homology (boxed) have been previously discussed (Spaete & Mocarski, 1985a) . The (G + C)-rich homology to the HSV-1 a sequence between nucleotides 182 and 217 is underlined and the region of occasional 51 bp deletion in CMV (Towne) is indicated by the A above the sequence. Pertinent restriction sites within the CMV (Towne) and CMV (AD169) L-S junction are indicated above and below the sequence, respectively. (b) Nucleotide sequence from the herpes pac homology (boxed) across the a to a boundary of the CMV (Towne) L-S junction fragment. The transition point is indicated by an arrowhead. The nucleotide sequence of the S-terminal clone is underlined. All sequencing was performed using established protocols (Maxam & Gilbert, 1980; Spaete & Mocarski, 1985a) .
for a number of herpesviruses . Therefore, in the four human herpesviruses studied in detail, the cleavage event occurs a relatively defined distance of 30 to 35 bp from this homology. When the S terminal clone was aligned with the b to a and a to a transitions found in complete a sequences, one base pair was missing. This characteristic is reminiscent of plasmid clones derived by analogous methods from the HSV-1 genome (M0carski & Roizman, 1982) , where a 3' single base extension present on virion DNA was removed in the process of cloning. Although we did not sequence an L terminus, our data are reasonably consistent with those of Tamashiro & Spector (1986) . One distinct region of variability was noticed in the process of determining the nucleotide sequence of the two a sequences within pON230. A 51 bp region (nucleotides 592 to 642) was deleted in one copy of the a sequence relative to the previously reported L-S junction sequence, as depicted in Fig. 2 . This deletion, which we shall refer to as a~, was found only in pON230 among the series of clones we analysed. The alignment ofCMV (Towne) and CMV (AD169) L-S junction sequences (Fig. 2 ) revealed that this region had no counterpart in CMV (AD169). Deletion a~ could be demonstrated by differences in size of restriction fragments spanning the region and by the fact that the NarI site usually present within the a sequence was lost. In order to assess the presence and distribution of a~ in the CMV (Towne) genome, we digested purified Fig. 1 ) probe using established procedures (Southern, 1975; Spaete & Mocarski, 1985a) . Plasmids pON230 and pON 231 provide controls for the migration of the 711 bp MluI-MluI fragment with the 51 bp deletion and for migration of the non-deleted 613 bp DdeI-MluI fragment (or the 610 bp S-terminal MluI fragment with which it comigrates). The seven different samples of CMV (Towne) DNA, made from different passage levels over a 2 year period, were run in parallel (lanes marked 1 to 7) demonstrating the stable occurrence of the 51 bp deletion in a proportion of a sequences in virion DNA. (b) Diagrammatic representation of the fragments generated by DdeI/Mlul digestion of CMV DNA. The lines represent viral genomes with variable numbers and all possible types (a and a~ sequences). The maps show the types of fragments arising from any of the possible distributions of a and a~. The probe fragment is indicated by the hatched boxed areas and the various types of fragments hybridizing to the probe are drawn above and below the representations of the CMV genomes. Note that the S-terminal fragments will comigrate with DdeI-MluI fragments because the DdeI site in the b sequence is within three base pairs of the a to b boundary in the b sequence.
viral D N A with MluI, which cleaves once in every a sequence irrespective of the absence of the deleted region, and DdeI, which cleaves once just outside the a sequence in the b sequence (see Fig. 2 ). After digestion of seven different batches o f C M V (Towne) DNA, each from a different passage level of CMV (Towne) following plaque purification, electrophoretic separation in a 1 agarose gel and transfer to nitrocellulose, the D N A was hybridized with a probe from within an a sequence (the 158 bp Aval fragment from nucleotide 482 to 640 in Fig. 2 ). As shown in Fig. 3 , both a and a~ were distributed in the viral genome. The relative abundance of a and aA in each different preparation of DNA was approximately 70% and 30%, respectively, indicating that the variability was a stable characteristic of CMV (Towne) DNA and unlike the instability of the more complex heterogeneities observed in CMV (AD169) by Tamashiro & Spector (1986) .
To determine whether the distribution of a and a~ was random or at particular locations in the viral genome, a series of digestions with NarI, Narl plus KpnI, and NarI plus XhoI were performed on viral DNA. Because there are no internal NarI sites in a~ sequences, a series of fragments can be predicted on the basis of the relative distribution of aA at the termini or L-S junction of the viral genome. Results of this analysis indicated that a~ may be present at any position in the viral genome otherwise occupied by an a sequence (data not shown).
We have established the structural domain of the CMV (Towne) a sequence and shown that the position of the cleavage giving rise to genomic termini is within a relatively defined distance from a region of short sequence homology observed near the ends of all herpesvirus DNAs studied to date. We have shown the level of heterogeneity within this region of the viral genome is much simpler in CMV (Towne) than in CMV (AD169). Although it has several structural features analogous to the HSV a sequence, the CMV (Towne) a sequence is not flanked by direct repeats. The significance of this difference depends on the functional importance of two copies of DR1 in a sequence function. Several groups (Mocarski & Roizman, 1982; Mocarski et al., 1985a; Varmuza & Smiley, 1985) have demonstrated that two copies of DR1 are not essential for the HSV-1 a sequence to act as a cleavage/packaging site. Furthermore, the CMV (Towne) a sequence can function as a cis element in HSV-1 packaging (Spaete & Mocarski, 1984 , demonstrating that naturally occurring a sequences without two copies of DR1 function appropriately.
In CMV (Towne) we have observed a significantly lower degree of variability within and around the a sequence compared to CMV (AD169) (Tamashiro et al., 1984; Tamashiro & Spector, 1986) . With the exception of our previous report of a sequence amplification occurring at both termini as well as at the L-S junction in CMV (Towne) (Spaete & Mocarski, 1985 a) , we have observed only one other major form of heterogeneity: the variable presence of a 51 bp region within an a sequence. We demonstrated the random distribution of this variable region within CMV (Towne) a sequences. The functional relevance of this deletion remains to be determined.
The distance from the short sequence homology to the apparent cleavage site for the five human herpesviruses (Davison, 1984; Davison & Wilkie, 1981 ; Mocarski et al., 1985a; van den Berg et al., 1984) , is uniformly 30 to 35 bp from the region of homology. This sequence has also been conserved in tupaia herpesvirus (Albrecht et al., 1985) , herpesvirus saimiri (Bankier et al., 1985) and murine cytomegalovirus (D. H. Spector, J. R. Marks & J. C. Tarnashiro, personal communication). The observation that CMV and HSV share this region and its suspected importance in cleavage and packaging are consistent with our previous reports (Spaete & Mocarski, 1984 ) that the CMV (Towne) a sequence could provide cis signals for HSV-1 cleavage/packaging. We have therefore designated this homology the 'herpes pac homology' (Fig. 1) . Our interpretation is consistent with the data of Varmuza & Smiley (1985) , who show that in HSV-1 even severe sequence alterations between the pac homology and the cleavage site (replacement with sequences from a portion of the HSV thymidine kinase gene) do not alter the cleavage distance from the pac homology. Besides this striking homology, there is one other region of sequence similarity amongst herpesviruses . This region is a relatively (G + C)-rich sequence between nucleotides 182 and 217 in the CMV (Towne) a sequence (Spaete & Mocarski, 1985a) and nucleotides 665 and 634 in the HSV-1 a sequence (Mocarski & Roizman, 1981) . Together, our observations suggest that the packaging of progeny DNA into capsids for biologically diverse groups of herpesviruses may occur by similar, evolutionarily conserved mechanisms.
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